# Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.

> **NCT03809182** · PHASE4 · COMPLETED · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 40 (actual)

## Conditions studied

- Bariatric Surgery Candidate
- Glucose Intolerance
- Insulin Resistance

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** 0.9% Sodium-chloride
- **DRUG:** Fentanyl
- **DRUG:** Morphine Sulfate

## Key facts

- **NCT ID:** NCT03809182
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-27
- **Primary completion:** 2013-07-25
- **Final completion:** 2013-07-25
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809182, "Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03809182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*